Science and Technology Innovation Program
February 2007 - White paper evaluates distributed sensing systems for water quality assessment and management.
January 2007 - Sheila Riley reports in Investor's Business Daily on how govenment agencies like the EPA are using serious games to teach important concepts.
"Prioritizing nanotechnology risk research isn't rocket science," says Project on Emerging Nanotechnologies chief scientist Andrew Maynard.
Comments by David Rejeski in advance of the meeting on Research Needs and Priorities Related to the Environmental, Health, and Safety Aspects of Engineered Nanoscale MaterialsJan 03, 2007
Research Needs and Priorities Related to the Environmental, Health, and Safety Aspects of Engineered Nanoscale MaterialsJan 03, 2007
Testimony by Andrew D. Maynard, Ph.D.Chief Science Advisor Project on Emerging Nanotechnologies
January 2007 - How many players does it take to balance the budget? David Rejeski wants you to put on your game face.
"Nanoscale science and engineering promise to be as important as the steam engine, the transistor, and the Internet, and have the potential to revolutionize all other technologies" according to Neal Lane, former science advisor to U.S. President Bill Clinton. "But that outcome is not guaranteed."
Tell a friend you are buying them a nanotechnology gift for the holidays, and visions of Star Trek collectables or geeky electronic toys may start to dance in their heads. But nanotechnology gifts can include everything from silver nanoparticle enhanced food storage containers to to fleece jackets and gloves from the Lands' End™ catalog—with Nano-Tex® Resists Static treatment.
A new report released today, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? by Michael Taylor, a former Deputy Commissioner for Policy at the Food and Drug Administration (FDA), examines the agency's capacity to properly regulate new products containing nanotechnology materials—including food, drugs, medical devices, dietary supplements and cosmetics.
Today at a hearing of the U.S. House of Representatives Committee on Science, Dr. Andrew Maynard testified that nanotechnology is being jeopardized by the lack of a clear federal strategy for examining possible environmental, health and safety risks and by inadequate funding for this work.